Remdesivir cuts risk of severe COVID-19 by 87 percent in non-hospitalized patients
By
Alicia Lasek
Jan 21, 2022
The results suggest that remdesivir (brand name Veklury) could be used to treat outpatients early in the disease course, researchers say. The drug currently is authorized for use only in hospitalized COVID-19...
Long-term care left behind in race to nab COVID monoclonal antibodies: report
Nov 02, 2021
Delayed shipments of antibody doses are putting residents’ lives at risk after federal authorities barred direct orders of the drugs, LTC clinicians say.